According to the 2024CSCO guidelines for esophageal cancer, artificial nutrition is recommended for patients with malnutrition (weight loss within 6 months) >10%, BMI<18.5kg/m2, or serum albumin <30g/L in patients without liver dysfunction. This evidence concerns the gene ALB and esophageal cancer.